Autologous T Cells
A Phase I Study of Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, and Other Hematologic Malignancies
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 1
- Enrollment
- 86 patients (estimated)
- Sponsors
- National Cancer Institute (NCI)
- Tags
- T Cell
- Trial Type
- Treatment
- Last Update
- 13 hours ago
- SparkCures ID
- 2085
- NCT Identifier
- NCT06904066
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.